University of Texas/Texas AM Investment Management Co (UTIMCO)’s Beam Therapeutics BEAM Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59,839	Closed	-$1.83M	–	19
2023 Q1	$1.83M	Buy	+59,839	New	+$2.36M	0.7%	7
2021 Q3	–	Sell	-224,391	Closed	-$28.9M	–	42
2021 Q2	$28.9M	Buy	224,391 +1	+0%	+$80	22.15%	2
2021 Q1	$18M	Buy	+224,390	New	+$21.3M	10.54%	3

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s BEAM Position: Q2 2023 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 59,839 shares — an estimated $1.83M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BEAM in Q1 2021 and held it in 3 quarters. The position peaked at $28.9M in Q2 2021. 194 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
University of Texas/Texas AM Investment Management Co (UTIMCO) sold 59,839 Beam Therapeutics shares in Q2 2023, an estimated $1.83M.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Beam Therapeutics in Q1 2021 and held it in 3 quarters.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Beam Therapeutics position peaked at $28.9M in Q2 2021.
194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2023, filed 4 Aug 2023.